WO2011065319A1 - ヒト治癒能力向上装置及びヒト治癒能力向上装置の作動法 - Google Patents
ヒト治癒能力向上装置及びヒト治癒能力向上装置の作動法 Download PDFInfo
- Publication number
- WO2011065319A1 WO2011065319A1 PCT/JP2010/070771 JP2010070771W WO2011065319A1 WO 2011065319 A1 WO2011065319 A1 WO 2011065319A1 JP 2010070771 W JP2010070771 W JP 2010070771W WO 2011065319 A1 WO2011065319 A1 WO 2011065319A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pressure
- healing ability
- human healing
- airtight
- human
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
- A61G10/00—Treatment rooms or enclosures for medical purposes
- A61G10/02—Treatment rooms or enclosures for medical purposes with artificial climate; with means to maintain a desired pressure, e.g. for germ-free rooms
- A61G10/023—Rooms for the treatment of patients at over- or under-pressure or at a variable pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H33/00—Bathing devices for special therapeutic or hygienic purposes
- A61H33/14—Devices for gas baths with ozone, hydrogen, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H33/00—Bathing devices for special therapeutic or hygienic purposes
- A61H33/14—Devices for gas baths with ozone, hydrogen, or the like
- A61H2033/143—Devices for gas baths with ozone, hydrogen, or the like with oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/50—Control means thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H33/00—Bathing devices for special therapeutic or hygienic purposes
- A61H33/06—Artificial hot-air or cold-air baths; Steam or gas baths or douches, e.g. sauna or Finnish baths
- A61H33/066—Cabins therefor
Definitions
- the present invention relates to a human healing ability improving device that utilizes the decompression of air and the return pressure to a normal pressure state, and further relates to an operation method of the human healing ability improvement device.
- An air bath is a method of preventing a disease by exposing the body to a specific air environment and training the body using the physical properties and chemical components of the air.
- Air baths have equally good effects on the regulation of blood circulation and on the tissue organs of the human body. Trace elements, inorganic salts, oxygen, etc. in the air can improve the vitality and immune function of the organism, and absorbing fresh air and improving the oxygen content in the blood protects cardiopulmonary function It is said that it will be a very effective aid.
- air temperature air temperature
- body temperature mainly stimuli formed by the difference between air temperature (air temperature) and body temperature.
- Cold changes in temperature activate the body's thermoregulatory function, the cerebral cortex and the reflex center of vasomotion, and can be well trained.
- cold air stimulation causes blood vessels on the surface of the body to contract, causing blood to flow toward the viscera.
- warm air stimulation dilates blood vessels on the surface of the body and causes blood to flow toward blood vessels on the surface of the body.
- the air bath is expected to have a stress relieving effect not only in humans but also in animals.
- One of the inventors of the present invention has proposed an optimum pressure regulating device and pressure regulating method for performing an air bath using a stimulus due to a temperature difference (see Patent Document 1).
- the apparatus for improving human healing ability includes an airtight part capable of airtightness, a decompression pump that communicates with an exhaust port of the airtight part to reduce the air pressure in the airtight part, and an air pressure of the airtight part Is a device comprising an over-decompression preventing device that prevents an over-depressurized state below a predetermined threshold pressure, Further comprising a decompression control means for controlling the decompression pump;
- the decompression control means changes the pressure in the hermetic portion to a decompressed state equal to or higher than the threshold pressure in 1 to 60 minutes, and from 1 to 60 minutes to normal pressure or higher than the decompressed state.
- the pressurizing step of changing to a lower range of normal pressure is continuously and repeatedly controlled.
- the human healing ability improving apparatus according to the invention described in claim 2 is such that the pressure reduction control means according to claim 1 increases the pressure change per unit time of the pressurizing process as compared with the pressure reducing process. It is characterized by this.
- a human healing ability improving device is characterized in that the airtight part described in claim 1 or 2 holds the entire human body inside.
- a human healing ability improving device is characterized by further comprising an oxygen deficiency preventing means for preventing oxygen deficiency in the airtight part according to claim 3.
- the operation method of the human healing ability improving apparatus includes an airtight part that can be airtight, a decompression pump that communicates with an exhaust port of the airtight part and reduces the pressure in the airtight part, and the airtight part
- a pressure reducing step in which the pressure in the airtight portion is reduced to a reduced pressure state equal to or higher than the threshold pressure in 1 to 60 minutes to reduce the temperature in the airtight portion by adiabatic expansion; It is characterized by continuously repeating a pressurizing step of pressurizing to a wide range of normal pressure higher than the normal pressure and lower than the normal pressure to restore the temperature in the airtight part to be higher than the temperature of the original airtight part. is there.
- the operation method of the human healing ability improving device according to the invention described in claim 6 is the same as that of the decompression process in the continuous repetition of the decompression process and the pressurization process according to claim 5. It is characterized by increasing the pressure change per unit time of the process.
- an operation method of the human healing ability improving device wherein the airtight portion according to the fifth or sixth aspect holds the entire human body inside. is there.
- the present invention has an effect that it is possible to obtain a human healing ability improving device and an operating method of the human healing ability improving device that can satisfactorily give a stimulus for improving the natural healing power of a living body.
- shaft shows atmospheric pressure (hPa) and a horizontal axis shows time (min).
- hPa atmospheric pressure
- min time
- shaft is the oxygen utilization rate (%) in an expiration, altitude (m)
- the axis indicates the operation time (min).
- the broken line indicates the required oxygen amount
- the solid line indicates the amount of oxygen acquired by the defense mechanism
- the alternate long and short dash line indicates the increased amount of ATP production.
- FIG. 5 is a plan view of FIG. 4.
- FIG. 5 is a side view of FIG. 4.
- FIG. 5 is a flowchart showing driving of the control device of FIG. 4,
- FIG. A is a flowchart showing a pressure reducing step, and
- FIG. B is a flowchart showing a pressurizing step.
- a1 is “pressure reduction pump drive”, a2 is “airtight portion atmospheric pressure measurement”, a3 is “target pressure reduction value”, a4 is “pressure reduction pump stop”, b1 is “pressure reduction control valve opening large”, b2 is “Airtight section pressure measurement”, b3 indicates “target reduced pressure value”, and b4 indicates “small pressure reducing valve opening”.
- shaft shows atmospheric pressure (hPa) and temperature (degreeC), and a horizontal axis shows time (min).
- an airtight part that can be airtight
- a decompression pump that communicates with an exhaust port of the airtight part to reduce the pressure inside the airtight part, and a predetermined threshold value for the air pressure of the airtight part
- An over-depressurization prevention device for preventing over-depressurization below atmospheric pressure, Further comprising a decompression control means for controlling the decompression pump;
- the decompression control means changes the pressure in the hermetic portion to a decompressed state equal to or higher than the threshold pressure in 1 to 60 minutes, and from 1 to 60 minutes to normal pressure or higher than the decompressed state.
- the pressurizing step for changing to a lower range of normal pressure is continuously and repeatedly controlled.
- the pressure change per unit time in the pressurizing step is increased as compared with the pressure reducing step.
- the “pressure change per unit time” is indicated by an inclination in a drawing in which time is plotted on the vertical axis and time is plotted on the horizontal axis as shown in FIG. 1, for example. That is, for example, the pressure reduction process is 205 / 14 ⁇ 14.6 (hPa / min) in which the pressure reduction process is reduced from 1000 hPa to 795 hPa over 14 minutes, whereas the pressurization process starts from 795 hPa over 4 minutes.
- “Human healing ability” added in the present invention refers to the ability to restore an abnormal state to a healthy state by the recovery function that the living body originally has. Specifically, the following (1) to (1) It is considered that the power shown in (3) is integrated.
- Natural metal-healing power The ability of human beings as human beings and not getting sick during the process of biological evolution
- Natural healing ability the ability to adapt to changes in the natural environment (heat, cold, etc.) and social environment (stress, etc.)
- Self-healing ability the ability of a sick person to cure himself,
- “improvement of human healing power” means to improve the natural healing power itself, the speed of the reaction to quickly recognize that it is in an abnormal state, and the response to return to the normal state It also includes further improving the speed and the like.
- the change in the atmospheric pressure cycle of the present invention stimulates the subject in the airtight part and improves the natural healing power (biological homeostasis maintenance mechanism) of the subject. More specifically, it seems to improve the responsiveness of the work to return a disease such as a disorder of various functions of the body or an abnormal state of unhealthy state to a normal state.
- the threshold pressure of the present invention varies among individuals, and the pressure threshold varies depending on a healthy person or a person suffering from a disease.
- the threshold can be lowered by experience, and conversely, the threshold may be increased by physical condition.
- a pressurized cabin in an aircraft is set to an atmospheric pressure state (about 780 hPa) at an altitude of 2000 m at an altitude of 12000 m and can be used even by a person suffering from a disease. Therefore, the threshold value of a general healthy subject is set to 700 hPa or more at an altitude of about 3000 m or less, at least exceeding an altitude of 2000 m.
- the decompression control means of the decompression pump according to the present invention may be any means that continuously and repeatedly controls the atmospheric pressure cycle that changes between the decompression state and the broad normal pressure state.
- the depressurized state refers to a depressurized state that is equal to or higher than a threshold pressure, and the value of the depressurized state is also changed according to a healthy person or a sick person.
- the reduced pressure state is an atmospheric pressure of an altitude of 1000 m
- the wide normal pressure state is an atmospheric pressure of an altitude of 50 m
- the pressure change between the reduced pressure state and the wide normal pressure state is repeated.
- the preferable reduced pressure state is 700 hPa or more and 950 hPa or less at an altitude of 3000 m, more preferably 800 hPa or more and 900 hPa or less, and the preferred wide normal pressure state is normal pressure (1013 hPa) or less and 1000 hPa or more corresponding to an altitude of 100 m.
- the decompression state which repeats continuously should just be decompression more than threshold air pressure, and does not need to be the same atmospheric pressure.
- the first reduced pressure state may be a different reduced pressure state such as 780 hPa corresponding to an altitude of 2000 m and the second reduced pressure state may be 700 hPa corresponding to an altitude of 3000 m.
- the repeated normal atmospheric pressure state may be normal pressure or an atmospheric pressure higher than the immediately preceding reduced pressure state and lower than the normal pressure, and may not be the same atmospheric pressure.
- the first wide normal pressure state may be a normal pressure (1013 hPa)
- the second wide normal pressure state may be a different atmospheric pressure state such as 989 hPa corresponding to an altitude of 200 m.
- the speed of the change from the reduced pressure state in the airtight part to the wide range normal pressure state, or from the wide range normal pressure state to the reduced pressure state may be anything that gives a stimulus that improves the natural healing effect of the test subject. It seems that the stimulation which improves the natural healing power effect of a test subject can be given if it is the speed which requires. For example, there is one that changes from a reduced pressure state to a broad normal pressure state in 1 to 60 minutes, or from a wide normal pressure state to a reduced pressure state in 1 to 60 minutes.
- the pressure is changed from normal pressure (about 1013 hPa) to an atmospheric pressure (about 900 hPa) corresponding to an altitude of 1000 m in 3 minutes, or subsequently changed to an altitude of 200 m (about 989 hPa) in 1.5 minutes. Can be repeated continuously.
- the size of the hermetic portion and the capacity of the vacuum pump it is possible to bring about a sudden pressure change that causes adiabatic expansion, and the volume that can quickly change the pressure between the reduced pressure state and the wide normal pressure state. That's fine.
- an airtight part with a large capacity it is sufficient to provide one or more decompression pumps with a large capacity and supply at least one air supply means with a large capacity for the airtight part.
- the device itself does not have to be large.
- As a large airtight part it is possible to realize a room having a capacity that allows several people to bathe at the same time.
- capacitance of the grade which one person lies down is raised.
- an airtight part with a small capacity that can accommodate pets such as dogs and cats is also possible.
- the “human healing ability improving device” is a “biological healing ability improving device”.
- the airtight portion of the present invention the entire human body is held inside.
- the airtight part holds the entire human body inside, and the airtight part is configured as a room where all the human body enters, and the subject enters the airtight room and repeats the pressure change between the reduced pressure state and the wide normal pressure state.
- oxygen deficiency prevention means for preventing oxygen deficiency in the hermetic portion is further provided.
- an intake pipe for introducing outside air below the displacement of the decompression pump into the airtight part is installed so that the outside air is naturally sucked according to the air pressure in the airtight part, or automatically at the time of power failure, etc.
- a door or a vent opening that is opened to prevent oxygen deficiency in the airtight part.
- the human healing ability improving apparatus of the present invention includes one or more other various means for improving the natural healing power of the living body that has entered the hermetic part, in addition to the decompression control means, the oxygen deficiency prevention means, and the like. May be.
- an oxygen supply means for increasing the oxygen partial pressure in the hermetic portion that decreases in the reduced pressure state
- a humidifying means for imparting humidity in the hermetic portion that decreases in the reduced pressure state
- You may provide further the heating means for providing the temperature in the airtight part which falls, and may further provide the negative ion provision means for increasing the negative ion in an airtight part.
- an airtight part capable of airtightness
- a decompression pump communicating with the exhaust port of the airtight part to reduce the pressure inside the airtight part, and the air pressure of the airtight part being lower than a predetermined threshold pressure
- An operation method of a human healing ability improvement device provided with an over-decompression preventing device for preventing over-decompression,
- a pressure reducing step in which the pressure in the airtight portion is reduced to a reduced pressure state equal to or higher than the threshold pressure in 1 to 60 minutes to reduce the temperature in the airtight portion by adiabatic expansion;
- Improve human healing ability by continuously repeating a pressurization process that restores the temperature in the airtight part to a temperature higher than the original airtight part by applying pressure to a wide range of normal pressure higher than the normal pressure and lower than the normal pressure.
- the device can be activated.
- the human healing ability improving device in the present invention related to the method, similarly to the above-described human healing ability improving device, an airtight portion capable of airtightness, and a reduced pressure for reducing the pressure in the airtight portion in communication with an exhaust port of the airtight portion
- a pump and an over-decompression preventing device that prevents the air pressure of the airtight part from becoming an over-decompression pressure that falls below a predetermined threshold pressure, and each of the air-tight part, the decompression pump, and the over-decompression prevention device Is as described above.
- FIG. 2 is a diagram showing a change in oxygen utilization rate during expiration when the decompression step and the pressurization step are continuously and repeatedly controlled. This hypothesis focuses on the oxygen utilization rate in exhaled breath due to resting lung respiration. In view of energy metabolism, the amount of oxygen carried by hemoglobin must always be constant in order to produce “ATP”.
- oxygen equivalent to 25.0% of exhaled air is used on the flat ground, for example, the oxygen concentration decreases by 10% at an altitude of 1000 m, so it is considered that 27.8% oxygen in the exhaled air is used. . Similarly, it is considered that 31.3% is used at an altitude of 2000 m. This is all determined by the function of the biological “defense mechanism”. Up to 3000m altitude can be converted because there is a surplus in the amount of oxygen in the breath, but if it becomes thinner than that, there may be individual differences in the amount of oxygen adsorbed to hemoglobin, which may cause hypoxia damage.
- NO gaseous nitric oxide
- EDRF Endothelium-Derived Relaxing Factor
- NO as a signaling substance not only prevents plaque from causing infarction of arteries and veins, but also maintains normal blood pressure through arterial relaxation to regulate blood flow and prevent heart attacks It is known that it is produced in the body, and NO is regarded as a remarkable chemical substance for maintaining the health of the cardiovascular system produced in the body. Hypothesis 2 is that this signal transmission by NO is the main mechanism of action of the natural healing power improving effect of the present invention.
- FIG. 3 is an explanatory view for explaining the state of the blood vessel under normal pressure and reduced pressure.
- the blood vessel 2a disposed near the surface of the body 1a is pushed from the outside of the blood vessel 2a with a pressure that can counteract the blood pressure inside the blood vessel 2a. .
- the pressure itself that pushes the surface of the body 1b is reduced, so in the blood vessel 2b disposed near the surface of the body 1b, the blood vessel 2b
- the blood vessel 2b itself is expanded by the blood pressure inside the blood vessel 2b so that the resultant force of the opposing force of the tube wall itself and the pressure from the outside of the blood vessel 2b is balanced with the blood pressure inside the blood vessel 2b.
- the blood vessel When the outside air pressure is restored, the blood vessel returns from the expanded state to the conventional state.
- the substance that improves the natural healing power is secreted by repeating expansion and restoration as if massaged blood vessels.
- NO is also secreted by stimulation of shear stress caused by blood flow and relaxes smooth muscle cells of blood vessels.
- the relaxed state and the return state of the blood vessel are physically repeated continuously. Even if the secretion of NO is more easily promoted than this, it is no wonder that it supports the natural healing power improving effect of the present invention.
- NO was called endothelium-derived relaxing factor (EDRF)
- EDRF endothelium-derived relaxing factor
- PGI 2 Activate prostaglandin I 2 (PGI 2 ) synthase to increase PGI 2 production.
- PGI 2 works directly on vascular endothelial cells to increase intracellular cAMP concentration and increase NO production. NO synergistically increases the production of prostaglandin I 2 (PGI 2 ) (positive feedback).
- Blood vessel massage by changes in atmospheric pressure also secretes other signaling substances other than NO.
- (4-1) by improving production of plasminogen activator (t-PA), the fibrinolytic system is activated and thrombus is dissolved.
- t-PA plasminogen activator
- the blood vessel itself rejuvenates, and the effect of preventing abnormal blood pressure reduction, angina pectoris, cerebral thrombus, and intracerebral hemorrhage is achieved.
- IL-6 regulatory factor of humoral immunity
- IgG, IgM, and IgA production of IgG, IgM, and IgA is enhanced, is involved in T cell differentiation and activation, acts on hepatocytes, and induces acute phase proteins such as CRP and haptoglobin.
- an airtight part that can be airtight, a decompression pump that communicates with an exhaust port of the airtight part to reduce the pressure inside the airtight part, and a threshold pressure that a pressure of the airtight part is predetermined. What is necessary is just to be provided with the excessive pressure reduction prevention apparatus which prevents that it becomes the excessive pressure reduction below.
- the airtight part in this invention is not assumed when it pressurizes positively more than a normal pressure (atmospheric pressure), the pressurization of the grade slightly over a normal pressure is naturally possible as an error range.
- the airtight part of the present invention includes an airtight part that can withstand pressure change between a reduced pressure state equal to or higher than a threshold pressure and a normal pressure or a broad normal pressure state that is higher than the reduced pressure state and lower than the normal pressure. If it is.
- the material constituting the hermetic portion may be any material that maintains airtightness and can withstand the pressure change between the reduced pressure state and the wide range normal pressure state, and is made of metal, resin, wood or the like alone or in combination.
- the shape of the airtight portion may be any shape as long as it maintains airtightness and can withstand the pressure change between the reduced pressure state and the wide range normal pressure state. Since it is not low, there is no restriction on its shape as long as airtightness is maintained. For example, if a rectangular panel is combined and the airtightness of a joint part can be ensured, it may be configured as a hexahedral casing.
- the decompression pump of the present invention may be any pump that communicates with the exhaust port of the hermetic part and depressurizes the air pressure in the hermetic part, and is controlled by a decompression control means, such as a rotary pump (oil rotary pump), an oil diffusion pump, A vacuum pump such as a turbo molecular pump, an ion pump, a dry pump, a canal booster pump or the like can be used alone or in combination of one or more.
- a decompression control means such as a rotary pump (oil rotary pump), an oil diffusion pump,
- a vacuum pump such as a turbo molecular pump, an ion pump, a dry pump, a canal booster pump or the like can be used alone or in combination of one or more.
- the over-decompression preventing device of the present invention may be any device that prevents the pressure of the hermetic part from being over-depressurized below a predetermined threshold pressure, and automatically when the pressure of the hermetic part falls below the threshold. Or what provided the open valve forcibly opened in the communicating pipe which connects external air and an airtight part is mentioned.
- a device that supplies an outside air amount that is less than the amount of air exhausted by the decompression pump, or a subject who entered the inside of the air-tight portion feels a change, and from inside the air-tight portion A double, triple or more safety device such as an open valve that is operated to open an airtight state is preferably further provided.
- FIG. 4 is a front view showing the configuration of an embodiment of the human healing capability improvement device of the present invention.
- FIG. 5 is a plan view of FIG.
- FIG. 6 is a side view of FIG.
- the human healing ability improving apparatus 10 of this embodiment includes an airtight part 11 composed of a plurality of panel plates 30 and a vacuum pump 13 communicating with an exhaust pipe 12 having one end opened inside the airtight part 11.
- a filter 15 is attached to the outside of the airtight part 11 at the other end of the air supply pipe 14 whose one end is opened at a position facing the exhaust pipe 12 in the airtight part 11.
- the external appearance of the airtight part 11 is a housing composed of a plurality of panel plates 30 having substantially the same size. In this embodiment, it is composed of 14 panel plates.
- an entrance / exit panel 31 having an airtight door 32 provided with two windows 33 at the center is used.
- Three side panels 34 each having two windows 33 are connected and used on both side surfaces.
- Three ceiling panels 35 are connected to the ceiling surface. In the same manner as the ceiling surface, three floor panels 36 are connected to the floor surface.
- each panel plate 30 has a rim portion standing so as to surround four sides of the rectangle, and the panel plates adjacent to each other through the panel plates 30 or a joining member by the rim portion. 30 is connected.
- an elastic rubber plate By connecting an elastic rubber plate between the rim portions of the panel plates 30 to be joined or between the rim portion of the panel plates and the joining member, airtightness between the connecting portions is maintained.
- An air supply pipe 14 is arranged on one side of the front entrance panel 31, and a pressure control valve 16 is attached in the middle of the air supply pipe 14 to adjust the pressure loss caused by the opening degree of the pressure control valve 16.
- the opening degree of the pressure control valve 16 is performed by a control device 22 described later. Note that the pressure control valve 16 has a structure that cannot be completely closed, thereby functioning as an oxygen deficiency prevention means.
- An exhaust pipe 12 is arranged on the other side of the front entrance panel 31.
- An exhaust solenoid valve 17 is attached in the middle of the exhaust pipe 12, and a branch pipe 18 and an outside air are provided on the decompression pump 13 side.
- An over-decompression prevention pipe 20 that communicates with the outside air via the electromagnetic valve 19 is arranged.
- the airtight portion 11 is provided with a number of pressure sensors 21 for measuring the internal air pressure. When the air pressure in the airtight portion 11 falls below a preset threshold value due to some abnormality, the decompression pump 13 is stopped. Then, when the outside air solenoid valve 19 is opened and outside air is sucked in, excessive decompression can be prevented.
- a control device 22 as a decompression control means for controlling the drive of the decompression pump 13 is disposed above the decompression pump 13, and the numerical value of the pressure sensor 21 of the hermetic section 11 is also input to the control device 22, and the electromagnetic The drive of the valves 17 and 19 and the opening degree of the pressure control valve 16 are also controlled.
- FIG. 7 is a flowchart showing the driving of the control device of FIG. 4, FIG. 7a is a flowchart showing the pressure reducing process, and FIG. 7b is a flowchart showing the pressurizing process.
- the decompression pump 13 is driven by the control device 22. In this case, it goes without saying that the external electromagnetic valve 19 is closed and the exhaust electromagnetic valve 17 is opened.
- the opening of the pressure control valve 16 is set to the minimum opening so that rapid decompression is performed.
- the atmospheric pressure is periodically checked to determine whether the target pressure reduction value is set in advance.
- the pressure reduction pump 13 is stopped.
- the exhaust solenoid valve 17 is closed to maintain the pressure inside the hermetic portion 11.
- the pressure control valve 16 since the pressure control valve 16 has a structure that is not blocked, the pressure gradually increases when the drive of the decompression pump 13 is stopped. Therefore, in the case where the target decompression state is maintained for a long time, if the constant pressure rises with reference to the target pressure, the exhaust solenoid valve 17 is opened and the decompression pump 13 is driven again. Good.
- the control device 22 opens the opening of the pressure control valve 16 to increase the air pressure in the airtight portion 11.
- the internal air pressure is regularly checked by the pressure sensor 21 of the airtight portion 11 to determine whether the target pressure value is set in advance, and the target pressure value (wide normal pressure state) is obtained. In that case, the opening of the pressure control valve 16 is squeezed to the minimum.
- the pressure control valve 16 since the pressure control valve 16 has a structure that is not blocked, the pressure gradually increases to the normal pressure even when the opening of the pressure control valve 16 is minimized.
- control is performed to open the exhaust solenoid valve 17 and drive the decompression pump 13 again when a certain pressure rises with reference to the target pressure. May be.
- the room of the airtight part 11 of a present Example may be equipped with the apparatus which makes a test subject's living room comfortable, such as illumination, an air-conditioner, floor heating, a CD player, and a television, as needed.
- a test subject's living room such as illumination, an air-conditioner, floor heating, a CD player, and a television, as needed.
- an air conditioner it is necessary to ensure airtightness so that the drain in the room
- the change in the temperature in the hermetic part was measured by continuously repeating the pressurizing step of restoring the air temperature in the hermetic part to be equal to or higher than the initial temperature of the hermetic part without making the air pressure constant. The results are shown in Table 1.
- the depressurization step is from atmospheric pressure (1013 hPa) or an atmospheric pressure corresponding to an altitude of 200 m (989 hPa) to an atmospheric pressure corresponding to an altitude of 1000 m (900 hPa), and the pressurizing step is from an atmospheric pressure corresponding to an altitude of 1000 m (900 hPa) to an altitude of 200 m.
- the corresponding atmospheric pressure (989 hPa) or normal pressure (1013 hPa) was repeated in 2.5 minutes.
- the depressurization step is from atmospheric pressure (1013 hPa) or atmospheric pressure corresponding to an altitude of 200 m (989 hPa) to atmospheric pressure corresponding to an altitude of 3000 m (700 hPa), and the pressurizing step is from atmospheric pressure corresponding to an altitude of 3000 m (700 hPa) to an altitude of 200 m.
- the corresponding atmospheric pressure (989 hPa) or normal pressure (1013 hPa) was repeated in 6 minutes (8 minutes for the first and last pressure).
- Example 2 Verification of human healing ability improvement effect (conditions)
- the natural pressure by the living body can be reduced by continuously repeating the pressure reducing step for reducing the pressure to a threshold pressure or higher and the pressure applying step for setting the normal pressure or a broad normal pressure higher than the reduced pressure and lower than the normal pressure.
- Healing ability improvement effect appears.
- the human healing ability improvement effect was verified below.
- Example 3 Verification of human healing ability improvement effect (1)
- the test subject was a man in his 60s who suffered from hepatocellular carcinoma, and entered the human healing ability improving apparatus described above, and one cycle was continuously performed at intervals of about 5 times per week.
- treatment such as medication was in accordance with the doctor in charge before entering the room.
- the transition result of the tumor marker test time series information is shown in FIG.
- the vertical axis indicates abnormal prothrombin (PIVKA-2) and alphafetoprotein (AFP) values
- the horizontal axis indicates the time in months, and the first month after the start of entry (start) +1 month in the right direction around this 1st month? Sun ... to the left-January? Show the day.
- PIVKA-2 abnormal prothrombin
- AFP alphafetoprotein
- the tumor marker values of alpha fetoprotein (AFP) and abnormal prothrombin (PIVKA-2) that did not show any signs of improvement before entering the room are shown in FIG. It was found that after about 1 month, it gradually began to decrease, and after about 5 months, abnormal prothrombin (PIVKA-2) decreased to 20 and alphafetoprotein (AFP) decreased to about 5.
- AFP alpha fetoprotein
- Example 4 Verification of human healing ability improvement effect (2)
- the test subject was a woman suffering from breast cancer, and entered the human healing ability improving apparatus described above, and one cycle was continuously performed at intervals of about 5 times per week.
- treatment such as medication was in accordance with the doctor in charge before entering the room.
- the comparison results of leukocyte neutrophils and lymphocytes are shown in Table 3 and FIG.
- the vertical axis indicates the percentage (%) of neutrophils (black circles in the figure) and lymphocytes (white circles in the figure), and the horizontal axis indicates the time in months. 1 day, and +1 month to the right around this 1st month? Sun ... to the left-January? Show the day.
- FIG. 12 there was no sign of improvement before entering the room, but it was found that the percentage of neutrophils gradually decreased and the percentage of lymphocytes increased from the start of entry. In addition, as the proportion of lymphocytes increased, the weight increased and I felt better.
- Example 5 Verification of human healing ability improvement effect (3)
- the test subject was a woman in her 40s suffering from rheumatoid arthritis, and entered the above-mentioned human healing ability improving apparatus, and one cycle was continuously performed at intervals of about 5 times per week.
- treatment such as medication was in accordance with the doctor in charge before entering the room.
- the results of numerical transition of C-reactive protein and rheumatoid factor RAPA (rheumatoid arthritis particle agglitination) are shown in the following Table 4 and FIG.
- the vertical axis represents C-reactive protein (CRP) and RAPA values
- the horizontal axis represents the time in months
- the first examination day after entering the room was set to 0, and the examination was conducted every two months.
- rheumatoid factor RAPA black circle in the figure
- C-reactive protein white circle in the figure
- Example 6 Verification of human healing ability improvement effect (4)
- the test subject was a woman in her 50s who suffered from rheumatism, and entered the aforementioned human healing ability improving apparatus, and one cycle was continuously performed at intervals of about 5 times per week.
- treatment such as medication was in accordance with the doctor in charge before entering the room.
- the transition results of inflammatory reaction CRP and rheumatoid factor RF values are shown in the following Table 5 and FIG.
- the vertical axis indicates the value of the inflammatory reaction CRP (solid line in the figure) and the rheumatoid factor RF (broken line in the figure)
- the horizontal axis indicates the time (week), and the first examination day after the start of entry (start).
- the test results are 2, 4, and 8 weeks after the test date.
- Example 7 Verification of human healing ability improvement effect (5)
- the test subject is a woman in her 50s. It entered into the above-mentioned human healing ability improvement apparatus, and 1 cycle was continuously performed by the entrance interval of about 5 times / week.
- Fig. 15 is a diagram comparing bone density (YAM: young adult mean), where the vertical axis is% of YAM and the horizontal axis is measured during surgery with the right knee as an artificial joint 8 years ago. The bone density and the data after 6 months from the start of entering the room are shown. As shown in FIG. 15, the bone density eight years ago was about 82.5. It seems to be suitable for years in patients with rheumatism. The bone density measured when the left knee was made an artificial joint 6 months after entering the room was 120, and it was judged that the bone density was about 20 years old.
- Example 8 Verification of human healing ability improvement effect (6)
- the subject is a woman in her 50s with uterine fibroids.
- a subject whose ovary cancer had previously removed the right ovary and left the uterus and left ovary.
- treatment such as medication was in accordance with the doctor in charge before entering the room.
- the results are shown in FIG. FIG. 16 verifies the size of the largest uterine fibroid, the vertical axis is the size (cm) of the uterine fibroid, and the horizontal axis is just before the start of entry and 15 months after the start of entry.
- the tumor marker was normal, and the fibroids were reduced from ⁇ 6 cm to ⁇ 3 cm. Other scattered uterine fibroids were also shrinking. It should be noted that pain in the head, lower abdomen, ischia, sacrum, calf, instep, etc. improved as the number of times of entering the room increased, and recently, fatigue has been removed.
- Example 8 Verification of human healing ability improvement effect (7)
- the test subject is a woman in her 60s who suffers from type II diabetes.
- FIG. 17 is a diagram showing the transition result of glycated hemoglobin (HbA1c).
- the ordinate represents the glycated hemoglobin (HbA1c) ratio (%), and the abscissa represents just before the start of entry and 12 months later.
- glycohemoglobin (HbA1c) was 7.2%, and it was diagnosed as type II diabetes.
- the device entered the human healing ability improving apparatus described above, and one cycle was continuously performed at intervals of about 5 times per week.
- treatment such as medication was in accordance with the doctor in charge before entering the room.
- glycohemoglobin HbA1c
- Example 9 Verification of human healing ability improvement effect (8)
- the test subject is a male in his 60s suffering from type II diabetes.
- FIG. 18 is a diagram showing the transition result of glycated hemoglobin (HbA1c).
- the ordinate represents the glycated hemoglobin (HbA1c) ratio (%), and the abscissa represents just before the start of entry and 12 months later.
- the subject was suffering from eating and drinking over the years, or diabetes was poorly controlled and cholesterol and triglyceride levels were high for about 15 years.
- glycohemoglobin (HbA1c) was 8.2%.
- HbA1c glycated hemoglobin
- Example 11 Verification of human healing ability improvement effect (10)
- the depressurization step to make the depressurization state equal to or higher than the threshold pressure, and the pressurization step to make the normal pressure or a broad normal pressure state that is higher than the depressurization state and lower than the normal pressure is a constant pressure. It has been proved that the blood flow in the subject's limbs increases by continuously repeating without the above condition, so that the limbs become warm and warm. Moreover, it was also confirmed that the natural healing power improvement effect appears by repeating a decompression process and a pressurization process continuously. Therefore, the body temperature of the palm (palm) was measured as verification of the effect of the human healing ability improvement apparatus of this invention.
- the following verification data is obtained by continuously performing the 50-minute decompression step and the pressurization step shown in Table 6 and FIG. 20 three times continuously as one cycle.
- the pressure change per unit time in the pressurizing step is increased with respect to the depressurizing step. That is, the pressure was gradually reduced over a long time, and then repeatedly controlled so as to rapidly apply pressure.
- Table 7 and FIG. 21 show examples in which the decompression step and the pressurization step are continuously controlled at the same rate of change. 20 and 21, the vertical axis represents palm temperature (° C.) (black circle in the figure) and atmospheric pressure (hPa) (white circle in the figure), and the horizontal axis represents time (min).
- the palm temperature was measured over time.
- the palm temperature was measured with a skin infrared thermometer (trade name: Thermofocus® Pro®).
- the pressure reduction process and the pressurization process are the ones shown in Table 6 and FIG. It was confirmed that the palm temperature increased more than the equivalent pressure change. This tends to lower the palm temperature during the pressurizing step, but by reducing the time of this pressurizing step to be shorter than the depressurizing step, the palm temperature continues to decrease without being lowered. It is thought that it will rise.
- the 50-minute decompression step and the pressurization step shown in Table 6 and FIG. 20 were continuously repeated three times as one cycle.
- Example 13 Verification of human healing ability improvement effect (12)
- the test subject was a 65-year-old man who suffered from early (type I) gastric cancer and was pointed to a total gastrectomy operation at another hospital. Entering the aforementioned human healing ability improving apparatus was started, and one cycle was continuously performed at intervals of about 5 times / week. In addition, treatment such as medication was in accordance with the doctor in charge from the start of entering the room. The results are shown in the following Table 9 and FIG.
- FIG. 22 a diagram shows the white blood cell count, b diagram shows the lymphocyte count (%), and c diagram shows the lymphocyte count (cells / ml).
- Example 14 Verification of human healing ability improvement effect (13)
- the test subject was a 61-year-old woman suffering from left breast cancer (multiple 1.6 cm and 0.7 cm) and diabetes, and a total removal of the left breast was pointed out at another hospital. Entering the aforementioned human healing ability improving apparatus was started, and one cycle was continuously performed at intervals of about 5 times / week. In addition, treatment such as medication was in accordance with the doctor in charge from the start of entering the room. The results are shown in the following Table 10 and FIG.
- the vertical axis indicates that the first month after entering the room is the first day of the month, and that the first month of the month is 0/1. Sun ... to the left-January? Show the day.
- a diagram shows the white blood cell count
- b diagram shows the lymphocyte count (%)
- c diagram shows the lymphocyte count (cells / ml).
- the number of lymphocytes increased within one month after the start of entering the room. Examination of PET, CT, etc. confirmed that there was no metastasis in parts other than the left breast and that there was no infiltration with the pectoral fascia. For this reason, thermocoagulation was performed on +07 at another hospital, and the course is being observed. In addition, about diabetes, since it was easy, it turned out that the blood glucose level and the value of HbA1c are in the normal value in one month.
- Example 15 Verification of human healing ability improvement effect (14)
- the test subject was a 59-year-old woman suffering from ovarian cancer and diabetes, and surgery to remove all ovarian cancer was performed at another hospital (-1/08).
- One month after the operation entry into the human healing ability improving device was started, and one cycle was continued at intervals of about 5 times / week.
- treatment such as medication was in accordance with the doctor in charge from the start of entering the room. The results are shown in the following Table 11 and FIG.
- a diagram shows the white blood cell count
- b diagram shows the lymphocyte count (%)
- c diagram shows the lymphocyte count (cells / ml).
- the tumor markers CA19-9 and CEA for gastrointestinal cancer were normal values immediately after the start of admission.
- Example 16 Verification of human healing ability improvement effect (15)
- the test subject was a 61-year-old woman who had undergone surgery for sigmoid colon cancer 3 years and 4 months before entering the human healing ability improvement device at another hospital. Thereafter, brain metastasis was confirmed 10 months before entering the room. For this reason, radiation therapy (3 days out of hospital) was performed, but lung metastasis was confirmed 7 months before entering the room. Therefore, dendritic cell therapy (8 times in total) was performed 4 months before entering the room. Palliative care was recommended just before entering the room. Entering the human healing ability improving device was started, and one cycle was continuously performed at intervals of about 5 times per week. In addition, treatment such as medication was in accordance with the doctor in charge from the start of entering the room. The results are shown in the following Table 12 and FIG.
- a diagram shows the white blood cell count
- b diagram shows the lymphocyte count (%)
- c diagram shows the lymphocyte count (cells / ml).
- Example 17 Verification of human healing ability improvement effect (16)
- the test subject is a 41 year old male suffering from diabetes. Entering the aforementioned human healing ability improving apparatus was started, and one cycle was continuously performed at intervals of about 5 times / week. In addition, treatment such as medication was in accordance with the doctor in charge from the start of entering the room. The results are shown in the following Table 13 and FIG.
- FIG. 27 shows the transition result of a blood glucose level (mg / dl)
- b figure shows the transition result of HbAlc (%).
- the vertical axis of FIGS. a and b is blood glucose level (mg / dl) or HbAlc (%), and the horizontal axis is time (week).
- diabetes cases improved over time, and diabetes was almost completely cured in about half a year.
- Example 18 Verification of human healing ability improvement effect (17)
- the test subject was a 43 year old male with diabetes. Entering the aforementioned human healing ability improving apparatus was started, and one cycle was continuously performed at intervals of about 5 times / week.
- treatment such as medication was in accordance with the doctor in charge from the start of entering the room. The results are shown in the following Table 14 and FIG.
- FIG. 28 shows the transition result of a blood glucose level (mg / dl), and b figure shows the transition result of HbAlc (%).
- the vertical axis of FIGS. a and b is blood glucose level (mg / dl) or HbAlc (%), and the horizontal axis is time (week).
- diabetes cases improved over time, and diabetes was almost completely cured in about 3 months.
- the human healing ability improvement apparatus which can give the irritation
- the effect of human healing ability to return to tissues and body organs becomes more effective.
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Rehabilitation Therapy (AREA)
- Pulmonology (AREA)
- Accommodation For Nursing Or Treatment Tables (AREA)
Abstract
Description
前記減圧ポンプを制御する減圧制御手段を更に備え、
前記減圧制御手段が、1~60分間で気密部内の気圧を前記閾値気圧以上の減圧状態へ変化させる減圧工程と、1~60分間でこの減圧状態から常圧か前記減圧状態よりも高く常圧よりも低い広範常圧状態へ変化させる与圧工程とを、連続的に繰り返し制御するものであることを特徴とするものである。
前記気密部内の気圧を1~60分間で前記閾値気圧以上の減圧状態に減圧して気密部内の気温を断熱膨張作用によって低下させる減圧工程と、1~60分間でこの減圧状態から常圧又は前記減圧状態よりも高く常圧よりも低い広範常圧状態に与圧して気密部内の気温を当初の気密部の気温以上に復元する与圧工程とを、連続的に繰り返すことを特徴とするものである。
前記減圧ポンプを制御する減圧制御手段を更に備え、
前記減圧制御手段が、1~60分間で気密部内の気圧を前記閾値気圧以上の減圧状態へ変化させる減圧工程と、1~60分間でこの減圧状態から常圧か前記減圧状態よりも高く常圧よりも低い広範常圧状態へ変化させる与圧工程とを、連続的に繰り返し制御するものである。
(1) 自然冶癒力:人間がヒトとして、生物の進化の過程で得た病気にならないようになる力、
(2) 自然治癒能力:自然環境(熱さや寒さ等)や社会環境(ストレス等)が変化した時に適応していこうとする力、
(3) 自己治癒能力:病気の人が自分で自分を治そうとする力、
前記気密部内の気圧を1~60分間で前記閾値気圧以上の減圧状態に減圧して気密部内の気温を断熱膨張作用によって低下させる減圧工程と、1~60分間でこの減圧状態から常圧又は前記減圧状態よりも高く常圧よりも低い広範常圧状態に与圧して気密部内の気温を当初の気密部の気温以上に復元する与圧工程とを、連続的に繰り返すことにより、ヒト治癒能力向上装置を作動することができる。
生体の「防御機構」は低地から高地に向かう場合(即ち、酸素濃度の低いほうに向かう場合)は、その低地から高地への移動中において絶えず理論値(平地での酸素利用量と同じ酸素量)よりも多い酸素量を得るように作用すると考えられる。このことは、常圧状態から減圧状態への移動速度を変えても体温の上昇は認められることから「ATP」の産生が増加していることがわかる。
血管内皮細胞では、血流によるズリ応力等の刺激によりガス状の一酸化窒素(以下、「NO」と記す)が分泌される。このNOは、血管の内皮由来弛緩因子(EDRF:Endothelium-Derived Relaxing Factor)と呼ばれていた。この内皮由来弛緩因子がNOそのものであることを示し、シグナル伝達物質としてのNOの発見により、R.F.ファーチゴット氏、L.J.イグナロ氏、F.ムラド氏の3名が1998年のノーベル医学生理学賞を受賞している。
(1) 血圧を低下させる効果
を始め、次のような種々の効果を生じさせる。現在確認されている他の効果としては、
例えば、(4-1) プラスミノゲンアクチベーター(t-PA)の産生向上により、線溶系が活発化され、血栓を溶解する。これにより、血管自体が若返り、異常血圧の低下、狭心症、脳血栓、脳内出血の予防効果を奏する。
図4は本発明のヒト治癒能力向上装置の一実施例の構成を示す正面図である。図5は図4の平面図である。図6は図4の側面図である。図に示す通り、本実施例のヒト治癒能力向上装置10は複数のパネル板30で構成された気密部11と、この気密部11の内側に一端を開放した排気管12に連通する減圧ポンプ13と、気密部11内の排気管12と対向する位置に一端を開放した給気管14の他端部にはフィルター15を気密部11の外方に取付けられている。
このように閾値気圧以上の減圧状態とする減圧工程と、常圧又は前記減圧状態よりも高く常圧よりも低い広範常圧状態とする与圧工程とを連続して繰り返すことにより生体による自然な治癒能力向上効果が現れる。以下、ヒト治癒能力向上効果を検証した。
被験者は肝細胞癌を患った60歳代の男性であり、前述のヒト治癒能力向上装置に入室し、1サイクルを5回/週程度の入室間隔で継続して行った。尚、投薬等の治療は入室以前からの担当医師に従った。腫瘍マーカー検査時系列情報の推移結果を図11に示す。図11において、縦軸は異常プロトロンビン(PIVKA-2)及びアルファフェトプロティン(AFP)の数値、横軸は月単位の時間を示し、入室開始(start)を経た最初の月初めを0月1日と表記し、この0月1日を中心として右方向に+1月?日…、左方向に-1月?日…を示す。
被験者は乳癌を患った女性であり、前述のヒト治癒能力向上装置に入室し、1サイクルを5回/週程度の入室間隔で継続して行った。尚、投薬等の治療は入室以前からの担当医師に従った。白血球の好中球とリンパ球の比較結果を次の表3と図12とに示す。図12において、縦軸は好中球(図中、黒丸)及びリンパ球(図中、白丸)の割合(%)、横軸は月単位の時間を示し、入室を経た最初の月初め0月1日とし、この0月1日を中心として右方向に+1月?日…、左方向に-1月?日…を示す。図12に示す通り、入室する前には改善の兆候が見られなかったが、入室開始から徐々に好中球の割合が下がり、リンパ球の割合が増えてきたことが判った。また、リンパ球の割合が増えるに従い、体重も増加し、見た目も判るくらい元気になってきた。
被験者は関節リウマチを患った40歳代の女性であり、前述のヒト治癒能力向上装置に入室し、1サイクルを5回/週程度の入室間隔で継続して行った。尚、投薬等の治療は入室以前からの担当医師に従った。C反応性蛋白(C-reactive protein)とリウマチ因子RAPA(rheumatoid arthritis particle agglitination)の数値推移の結果を次の表4と図13とに示す。図13において、縦軸はC反応性蛋白(CRP)及びRAPAの数値、横軸は月単位の時間を示し、入室を経た最初の検査日を0とし、2ヶ月毎に検査を実施した。
被験者はリウマチを患った50歳代女性であり、前述のヒト治癒能力向上装置に入室し、1サイクルを5回/週程度の入室間隔で継続して行った。尚、投薬等の治療は入室以前からの担当医師に従った。炎症反応CRPとリウマトイド因子RF数値の推移結果を次の表5と図14とに示す。図14において、縦軸は炎症反応CRP(図中、実線)及びリウマトイド因子RF(図中、破線)の値、横軸は時間(週)を示し、入室開始(start)を経た最初の検査日を0とし、この検査日から2,4,8週間後の検査結果を示す。
被験者は50歳代女性である。前述のヒト治癒能力向上装置に入室し、1サイクルを5回/週程度の入室間隔で継続して行った。図15は骨密度(YAM:若年成人平均値(young adult mean))を比較した線図であり、縦軸はYAMに対する%、横軸は8年前に右膝を人工関節にする手術時に計測した骨密度及び入室開始から6ヶ月後のデータを示している。図15に示す通り、8年前の骨密度は82.5程度であった。リウマチ患者では年相応らしい。入室開始から6ヶ月後に左膝を人工関節にした時に計測した骨密度は120であり、二十歳くらいの骨密度であると判断されている。
被験者は子宮筋腫を有する50歳代女性である。以前に卵巣癌で右の卵巣を摘出され、子宮と左の卵巣は残されている被験者である。子宮筋腫が数個あり、一番大きいものがφ6cmであり、その他、φ4cmのものなどが数個あった。前述のヒト治癒能力向上装置に入室し、1サイクルを5回/週程度の入室間隔で継続して行った。尚、投薬等の治療は入室以前からの担当医師に従った。結果を図16に示す。図16は最も大きい子宮筋腫のサイズを検証したものであり、縦軸は子宮筋腫の大きさ(cm)、横軸は入室開始直前と、入室開始から15ヶ月後である。
被験者はII型糖尿病を患っている60歳代女性である。図17はグリコヘモグロビン(HbA1c)の移行結果を示す線図であり、縦軸はグリコヘモグロビン(HbA1c)割合(%)、横軸は入室開始直前と12ヶ月後を示す。図17に示す通り、入室直前ではグリコヘモグロビン(HbA1c)が7.2%であり、II型糖尿病であると診断された。その後、前述のヒト治癒能力向上装置に入室し、1サイクルを5回/週程度の入室間隔で継続して行った。尚、投薬等の治療は入室以前からの担当医師に従った。
被験者はII型糖尿病を患っている60歳代男性である。図18はグリコヘモグロビン(HbA1c)の移行結果を示す線図であり、縦軸はグリコヘモグロビン(HbA1c)割合(%)、横軸は入室開始直前と12ヶ月後を示す。被験者は、長年の暴飲暴食で発症したのか、もう15年くらいに糖尿病のコントロールが悪くコレステロールと中性脂肪の値も高かった。入室開始前の検診ではグリコヘモグロビン(HbA1c)が8.2%であった。
被験者は糖尿病、高血圧を罹患している70歳代女性である。図19はグリコヘモグロビン(HbA1c)の移行結果を示す線図であり、縦軸はグリコヘモグロビン(HbA1c)割合(%)、横軸は入室開始直前と12ヶ月後を示す。被験者は2004年ごろに糖尿病が発覚、血糖値が330だった。以前から中性脂肪やコレステロールが高く、血圧も高かった。
以上の通り、被験者の話によると、閾値気圧以上の減圧状態とする減圧工程と、常圧又は前記減圧状態よりも高く常圧よりも低い広範常圧状態とする与圧工程とを一定な圧力の状態がなく連続して繰り返すことにより、被験者の手足における血流が上昇するため、手足がぽかぽかと暖かくなることが証言された。また、減圧工程と与圧工程とを連続して繰り返すことにより自然な治癒力向上効果が現れることも確認された。よって、本発明のヒト治癒能力向上装置の効果の検証として、掌(手のひら)の体温を計測した。
被験者は卵巣癌に罹患している59歳の女性である。前述のヒト治癒能力向上装置に入室前の約2ヶ月前に摘出手術を行っていた。ヒト治癒能力向上装置に入室時は、頸部リンパ節転移、肝転移が判明した4期の被験者であった。前述のヒト治癒能力向上装置に入室し、1サイクルを5回/週程度の入室間隔で継続して行った。尚、投薬等の治療は担当医師に従った。結果を次の表8及び図22に示す。
被験者は早期(I型)胃癌を罹患しており、他院にて胃全摘手術を指摘されてた65歳の男性である。前述のヒト治癒能力向上装置への入室を開始し、1サイクルを5回/週程度の入室間隔で継続して行った。尚、投薬等の治療は入室開始からの担当医師に従った。結果を次の表9及び図23に示す。
被験者は、左乳房癌(多発性1.6cm及び0.7cm)及び糖尿病を罹患した61歳の女性であり、他院にて、左乳房の全摘出を指摘されていた。前述のヒト治癒能力向上装置への入室を開始し、1サイクルを5回/週程度の入室間隔で継続して行った。尚、投薬等の治療は入室開始からの担当医師に従った。結果を次の表10及び図24に示す。
被験者は、卵巣癌及び糖尿病を罹患した59歳の女性であり、他院にて、卵巣癌を全摘出する手術が行われていた(-1/08)。術後1ヶ月後からヒト治癒能力向上装置への入室を開始し、1サイクルを5回/週程度の入室間隔で継続して行った。尚、投薬等の治療は入室開始からの担当医師に従った。結果を次の表11及び図25に示す。
被験者は他院にてヒト治癒能力向上装置への入室を開始の3年4ヶ月前にS状結腸癌の手術を行った61歳の女性である。その後、入室を開始の10ヶ月前に脳転移が確認された。そのため、放射線治療(通院3日間)を行ったが、入室を開始の7ヶ月前に肺転移が確認された。そのため、入室を開始の4ヶ月前より樹状細胞療法(計8回)を施行した。入室の開始直前に緩和ケアを勧められた。ヒト治癒能力向上装置への入室を開始し、1サイクルを5回/週程度の入室間隔で継続して行った。尚、投薬等の治療は入室開始からの担当医師に従った。結果を次の表12及び図26に示す。
被験者は、糖尿病を罹患した41歳の男性である。前述のヒト治癒能力向上装置への入室を開始し、1サイクルを5回/週程度の入室間隔で継続して行った。尚、投薬等の治療は入室開始からの担当医師に従った。結果を次の表13及び図27に示す。
被験者は、糖尿病を罹患した43歳の男性である。前述のヒト治癒能力向上装置への入室を開始し、1サイクルを5回/週程度の入室間隔で継続して行った。尚、投薬等の治療は入室開始からの担当医師に従った。結果を次の表14及び図28に示す。
11…気密部、
12…排気管、
13…減圧ポンプ、
14…給気管、
15…フィルター、
16…圧力調節弁、
17…排気用電磁弁、
18…分岐管、
19…外気用電磁弁、
20…過減圧防止配管、
21…圧力センサ、
22…制御装置、
30…パネル板、
31…出入り口パネル、
32…気密扉、
33…窓、
34…側面パネル、
35…天井パネル、
36…床パネル、
Claims (8)
- 気密可能な気密部と、この気密部の排気口に連通して気密部内の気圧を減圧する減圧ポンプと、前記気密部の気圧が予め定められた閾値気圧を下回る過減圧となることを防止する過減圧防止装置とを備えた装置であって、
前記減圧ポンプを制御する減圧制御手段を更に備え、
前記減圧制御手段が、1~60分間で気密部内の気圧を前記閾値気圧以上の減圧状態へ変化させる減圧工程と、1~60分間でこの減圧状態から常圧か前記減圧状態よりも高く常圧よりも低い広範常圧状態へ変化させる与圧工程とを、連続的に繰り返し制御するものであることを特徴とするヒト治癒能力向上装置。 - 前記減圧制御手段が、前記減圧工程と比較して前記与圧工程の単位時間当たりの圧力変化を大きくするものであることを特徴とする請求項1に記載のヒト治癒能力向上装置。
- 前記気密部が人体の全部を内部に保持するものであることを特徴とする請求項1又は2に記載のヒト治癒能力向上装置。
- 前記気密部内の酸素の欠乏を防止する酸欠防止手段を更に備えたことを特徴とする請求項3に記載のヒト治癒能力向上装置。
- 気密可能な気密部と、この気密部の排気口に連通して気密部内の気圧を減圧する減圧ポンプと、前記気密部の気圧が予め定められた閾値気圧を下回る過減圧となることを防止する過減圧防止装置とを備えたヒト治癒能力向上装置の作動法であって、
前記気密部内の気圧を1~60分間で前記閾値気圧以上の減圧状態に減圧して気密部内の気温を断熱膨張作用によって低下させる減圧工程と、1~60分間でこの減圧状態から常圧又は前記減圧状態よりも高く常圧よりも低い広範常圧状態に与圧して気密部内の気温を当初の気密部の気温以上に復元する与圧工程とを、連続的に繰り返すことを特徴とするヒト治癒能力向上装置の作動法。 - 前記減圧工程と与圧工程との連続的な繰り返しの際に、減圧工程と比較して与圧工程の単位時間当たりの圧力変化を大きくすることを特徴とする請求項5に記載のヒト治癒能力向上装置の作動法。
- 前記気密部が、人体の全部を内部に保持するものであることを特徴とする請求項5又は6に記載のヒト治癒能力向上装置の作動法。
- 前記ヒト治癒能力向上装置が、外気を気密部内の気圧に応じて連続的に自然吸入する給気管を更に備えたことを特徴とする請求項1~7の何れか1項に記載のヒト治癒能力向上装置の作動法。
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/505,919 US9084711B2 (en) | 2009-11-24 | 2010-11-22 | Human healing ability enhancing apparatus and method for actuating human healing ability enhancing apparatus |
JP2011543240A JPWO2011065319A1 (ja) | 2009-11-24 | 2010-11-22 | ヒト治癒能力向上装置及びヒト治癒能力向上装置の作動法 |
KR1020127013228A KR101702934B1 (ko) | 2009-11-24 | 2010-11-22 | 인간 치유 능력 향상 장치 및 인간 치유 능력 향상 장치의 작동법 |
CN201080053100.0A CN102753132B (zh) | 2009-11-24 | 2010-11-22 | 人治愈能力提高装置及人治愈能力提高装置的工作方法 |
EP10833165.3A EP2505176A4 (en) | 2009-11-24 | 2010-11-22 | DEVICE FOR INCREASING HUMAN HEALTH CAPACITY AND METHOD FOR OPERATING THE DEVICE TO INCREASE HUMAN HEALTH ABILITY |
HK13104879A HK1177678A1 (en) | 2009-11-24 | 2013-04-23 | Human healing ability enhancing apparatus and method for actuating human healing ability enhancing apparatus |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009266237 | 2009-11-24 | ||
JP2009-266237 | 2009-11-24 | ||
JP2010-105054 | 2010-04-30 | ||
JP2010105054 | 2010-04-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2011065319A1 true WO2011065319A1 (ja) | 2011-06-03 |
Family
ID=44066424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2010/070771 WO2011065319A1 (ja) | 2009-11-24 | 2010-11-22 | ヒト治癒能力向上装置及びヒト治癒能力向上装置の作動法 |
Country Status (8)
Country | Link |
---|---|
US (1) | US9084711B2 (ja) |
EP (1) | EP2505176A4 (ja) |
JP (3) | JPWO2011065319A1 (ja) |
KR (1) | KR101702934B1 (ja) |
CN (1) | CN102753132B (ja) |
HK (1) | HK1177678A1 (ja) |
TW (1) | TWI516258B (ja) |
WO (1) | WO2011065319A1 (ja) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013105644A1 (ja) * | 2012-01-12 | 2013-07-18 | 有限会社秀岳 | 生体治癒能力向上装置 |
JP2013141570A (ja) * | 2012-01-12 | 2013-07-22 | Shugaku Ltd Co | 生体治癒能力向上装置 |
JP2014045941A (ja) * | 2012-08-31 | 2014-03-17 | Shugaku Ltd Co | 高地環境用生体治癒能力向上装置 |
JP2016077685A (ja) * | 2014-10-20 | 2016-05-16 | 日本気圧バルク工業株式会社 | 高圧低圧ルーム |
JP2016077684A (ja) * | 2014-10-20 | 2016-05-16 | 日本気圧バルク工業株式会社 | 高圧低圧ルーム |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015059273A1 (de) * | 2013-10-24 | 2015-04-30 | Bsn Medical Gmbh | Eintauchvorrichtung |
US10058471B2 (en) | 2014-02-21 | 2018-08-28 | William M. Vaughan | System and method of using hyperbaric oxygen therapy for treating concussive symptoms and musculoskeletal injuries and for pre-treatment to prevent damage from injuries |
US20180221241A1 (en) * | 2015-06-08 | 2018-08-09 | The Governors Of The University Of Alberta | Enhancement of vasodilatory function and lowering of effective systemic vascular resistance |
KR102104490B1 (ko) | 2015-12-07 | 2020-04-24 | 주식회사 엘지화학 | 이차 전지의 충전 방법 |
US20170340512A1 (en) * | 2016-05-25 | 2017-11-30 | Steven-Hunt Kang | Energizing bed |
JP7237829B2 (ja) * | 2016-11-11 | 2023-03-13 | ガイネソニックス, インコーポレイテッド | 組織の制御された治療と組織および/または治療データとの動的相互作用およびそれらの比較 |
EP3569215B1 (de) * | 2018-05-17 | 2020-09-09 | Klafs GmbH & Co. KG | Kabine zum dampfbaden von personen |
RU201120U1 (ru) * | 2020-07-06 | 2020-11-27 | федеральное государственное автономное образовательное учреждение высшего образования "Московский физико-технический институт (национальный исследовательский университет)" | Установка для проведения экспериментальных исследований на животных в гипоксических условиях при низких температурах |
CN113521672B (zh) * | 2021-06-21 | 2022-06-17 | 吉林大学中日联谊医院 | 一种神经内科运动训练组合装置 |
CN115487022B (zh) * | 2022-11-18 | 2023-03-17 | 云南典润洋科技有限公司 | 一种高气压富氧舱压力控制装置 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004202156A (ja) * | 2002-12-24 | 2004-07-22 | Michitomo Kawakami | 減圧室 |
JP2005312792A (ja) * | 2004-04-30 | 2005-11-10 | Mediate:Kk | 減圧・常圧併用の消毒方法および消毒装置 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0613042B2 (ja) * | 1989-02-27 | 1994-02-23 | 武一 敷浪 | 癌治療装置 |
US5000164A (en) * | 1989-06-26 | 1991-03-19 | The United States Of America As Represented By The Secretary Of The Navy | Circulation enhancing apparatus |
JP2613491B2 (ja) | 1990-11-06 | 1997-05-28 | 株式会社クボタ | ディーゼルエンジンのフランジ取付形燃料噴射ポンプの噴射時期微調整装置 |
US5467764A (en) * | 1992-02-19 | 1995-11-21 | Hyperbaric Mountain Technologies, Inc. | Hypobaric sleeping chamber |
US5503143A (en) * | 1994-02-17 | 1996-04-02 | Marion; Joseph | Method and apparatus for removing liquid from a patient's lungs |
CN1131708C (zh) | 2000-01-06 | 2003-12-24 | 烟台冰轮高压氧舱有限公司 | 一种高压氧舱计算机监控方法 |
US7263995B2 (en) * | 2001-02-28 | 2007-09-04 | Hyperbaric Technology, Inc. | Hyperbaric oxygen therapy system controls |
AU2002952811A0 (en) * | 2002-11-22 | 2002-12-05 | Oxygen Therapy International Pty Ltd | Hyperbaric therapy capsule |
JP2004202456A (ja) * | 2002-12-26 | 2004-07-22 | Komatsu Ltd | 2軸せん断型破砕機 |
US7198045B2 (en) * | 2003-02-10 | 2007-04-03 | Hollis Parker Risley | Low pressure hyperbaric chamber and method of using the same |
US8251057B2 (en) * | 2003-06-30 | 2012-08-28 | Life Support Technologies, Inc. | Hyperbaric chamber control and/or monitoring system and methods for using the same |
US7503322B2 (en) * | 2003-09-12 | 2009-03-17 | Harris Michael F | Methods for the treatment of HIV and other viruses |
JP2007044486A (ja) * | 2005-07-11 | 2007-02-22 | Yoichiro Yamanobe | 低圧室圧力制御方法 |
US7926483B2 (en) * | 2005-08-04 | 2011-04-19 | Sir Issac Newton Enterprises LLC | System for controlling pressure in defined environment and associated method |
JP2007075552A (ja) * | 2005-09-10 | 2007-03-29 | Yoichiro Yamanobe | 糖尿病治療装置 |
US8342353B2 (en) * | 2007-01-24 | 2013-01-01 | Bartlett Robert D | Interlock vessel for hyperbaric transfer system |
WO2008100924A1 (en) * | 2007-02-12 | 2008-08-21 | O'brien William J | Variable pressure chamber having a screw compressor |
CN101380263B (zh) | 2008-09-27 | 2010-12-01 | 姜林 | 生物内环境调理设备及其使用方法 |
JP4477690B1 (ja) * | 2009-01-23 | 2010-06-09 | 進盟 川上 | 調圧装置及び調圧装置の調圧法 |
-
2010
- 2010-11-22 WO PCT/JP2010/070771 patent/WO2011065319A1/ja active Application Filing
- 2010-11-22 JP JP2011543240A patent/JPWO2011065319A1/ja active Pending
- 2010-11-22 KR KR1020127013228A patent/KR101702934B1/ko active IP Right Grant
- 2010-11-22 EP EP10833165.3A patent/EP2505176A4/en not_active Withdrawn
- 2010-11-22 CN CN201080053100.0A patent/CN102753132B/zh active Active
- 2010-11-22 US US13/505,919 patent/US9084711B2/en active Active
- 2010-11-24 TW TW099140554A patent/TWI516258B/zh active
-
2013
- 2013-04-23 HK HK13104879A patent/HK1177678A1/xx unknown
-
2015
- 2015-08-20 JP JP2015162923A patent/JP6401128B2/ja active Active
-
2018
- 2018-06-04 JP JP2018106815A patent/JP6651572B2/ja active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004202156A (ja) * | 2002-12-24 | 2004-07-22 | Michitomo Kawakami | 減圧室 |
JP4175460B2 (ja) * | 2002-12-24 | 2008-11-05 | 洋一郎 山野邉 | 可搬式減圧室 |
JP2005312792A (ja) * | 2004-04-30 | 2005-11-10 | Mediate:Kk | 減圧・常圧併用の消毒方法および消毒装置 |
Non-Patent Citations (1)
Title |
---|
See also references of EP2505176A4 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013105644A1 (ja) * | 2012-01-12 | 2013-07-18 | 有限会社秀岳 | 生体治癒能力向上装置 |
JP2013141570A (ja) * | 2012-01-12 | 2013-07-22 | Shugaku Ltd Co | 生体治癒能力向上装置 |
JP2014045941A (ja) * | 2012-08-31 | 2014-03-17 | Shugaku Ltd Co | 高地環境用生体治癒能力向上装置 |
JP2016077685A (ja) * | 2014-10-20 | 2016-05-16 | 日本気圧バルク工業株式会社 | 高圧低圧ルーム |
JP2016077684A (ja) * | 2014-10-20 | 2016-05-16 | 日本気圧バルク工業株式会社 | 高圧低圧ルーム |
Also Published As
Publication number | Publication date |
---|---|
HK1177678A1 (en) | 2013-08-30 |
CN102753132B (zh) | 2014-06-18 |
JP6401128B2 (ja) | 2018-10-03 |
US9084711B2 (en) | 2015-07-21 |
JPWO2011065319A1 (ja) | 2013-04-11 |
JP2015205221A (ja) | 2015-11-19 |
EP2505176A4 (en) | 2015-04-01 |
TWI516258B (zh) | 2016-01-11 |
KR101702934B1 (ko) | 2017-02-06 |
US20120266874A1 (en) | 2012-10-25 |
KR20120106946A (ko) | 2012-09-27 |
JP6651572B2 (ja) | 2020-02-19 |
EP2505176A1 (en) | 2012-10-03 |
CN102753132A (zh) | 2012-10-24 |
JP2018130599A (ja) | 2018-08-23 |
TW201138753A (en) | 2011-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6401128B2 (ja) | ヒト治癒能力向上装置及びヒト治癒能力向上装置の作動法 | |
US10898121B2 (en) | Exercise apparatus simulating mild to high altitude environments | |
JP5271148B2 (ja) | 調圧装置及び調圧装置の調圧法 | |
JP4477690B1 (ja) | 調圧装置及び調圧装置の調圧法 | |
Kawai et al. | Abdominal respiration induces hemodilution and related reduction in ADH concentration of blood | |
JP6330988B2 (ja) | 生体治癒能力向上装置 | |
Wang et al. | Therapeutic study of hyperbaric oxygen on Heme Oxygenase-1 (HO-1) in patients with acute carbon monoxide poisoning and myocardial injury | |
JP5781273B2 (ja) | ヒトを除く動物用自然治癒力向上装置 | |
JP6074701B2 (ja) | 高地環境用生体治癒能力向上装置 | |
JP5666343B2 (ja) | 生体治癒力向上装置及び生体治癒力向上装置の作動法 | |
WO2013105644A1 (ja) | 生体治癒能力向上装置 | |
Zhu | Analysis of Preventive Measures Based on Current Research Status of Allergic Reactions | |
Zhu et al. | Case report–Acupuncture treatment in patient with high TSH (thyroidstimulating hormone) | |
US20180221241A1 (en) | Enhancement of vasodilatory function and lowering of effective systemic vascular resistance | |
Lichodziejewska-Niemierko et al. | High level of negative emotions in hemodialysis patients suggests the need for therapy | |
RU2357728C2 (ru) | Способ лечения экссудативного плеврита | |
WO2005084528A1 (fr) | Methode permettant d'evaluer les effets d'un moyen modulateur sur des pathologies physiologiques/psychologiques | |
Oral et al. | The Effect of One Session Osteopathic Manuel Treatment on Femoral Artery Diameter and Flow in Patients Diagnosed with Peripheral Arterial Disease | |
Slack | Hyperbaric oxygen | |
Tapia | IX International scientific conference of Russian Association of Ozone Therapy | |
Cook | TUBERCULOSIS: SOME PHASES OF TREATMENT | |
Mayer et al. | The Challenging Response of Physis to Inflammation Part5: Inflammatory Diseases, Processes and Outcomes. | |
Aleksandrov et al. | Some aspects of use of rotating magnetic field for medical treatment | |
Lazaron et al. | Stress Response and Multiple Organ Failure | |
Pauli et al. | plague or popular sickness would" spread itself and |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201080053100.0 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10833165 Country of ref document: EP Kind code of ref document: A1 |
|
REEP | Request for entry into the european phase |
Ref document number: 2010833165 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011543240 Country of ref document: JP Ref document number: 2010833165 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 20127013228 Country of ref document: KR Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13505919 Country of ref document: US |